mhurhangee/patent-ind-claim-en huggingface dataset:
An assembly, comprising: a shaft extending along an axis ; a bearing supporting the shaft, and receiving lubrication fluid; a stator seal element circumscribing the shaft; and a rotor seal element mounted on the shaft axially between the bearing and the stator seal element, the rotor seal element forming a seal with the stator seal element; characterised by : a shield substantially preventing the lubrication fluid from traveling axially away from the bearing onto the rotor seal element. a shaft extending along an axis ; a bearing supporting the shaft, and receiving lubrication fluid; a stator seal element circumscribing the shaft; and a rotor seal element mounted on the shaft axially between the bearing and the stator seal element, the rotor seal element forming a seal with the stator seal element; characterised by : a shield substantially preventing the lubrication fluid from traveling axially away from the bearing onto the rotor seal element.
A torque-limiting driver comprising: a body having a handle; an upper cylindrical shank comprising a plastic material or a composite including plastic; a lower cylindrical shank comprising a plastic material or a composite including plastic and having a drive socket ; a nut ; a spring between the upper cylindrical shank and the nut , wherein the spring is configured to apply a force across the upper cylindrical shank and the lower cylindrical shank ; a shaft having a workpiece-engaging tip and a drive connection engaged within the drive socket of the lower cylindrical shank , the shaft extending axially through the lower cylindrical shank , the upper cylindrical shank , and the spring and connected to the nut , and the shaft having a lumen extending across an axial length of the shaft ; and, wherein the upper cylindrical shank and the lower cylindrical shank engage for relative rotation, and wherein the upper cylindrical shank and the lower cylindrical shank disengage when a predetermined torque limit is exceeded. a body having a handle; an upper cylindrical shank comprising a plastic material or a composite including plastic; a lower cylindrical shank comprising a plastic material or a composite including plastic and having a drive socket ; a nut ; a spring between the upper cylindrical shank and the nut , wherein the spring is configured to apply a force across the upper cylindrical shank and the lower cylindrical shank ; a shaft having a workpiece-engaging tip and a drive connection engaged within the drive socket of the lower cylindrical shank , the shaft extending axially through the lower cylindrical shank , the upper cylindrical shank , and the spring and connected to the nut , and the shaft having a lumen extending across an axial length of the shaft ; and, wherein the upper cylindrical shank and the lower cylindrical shank engage for relative rotation, and wherein the upper cylindrical shank and the lower cylindrical shank disengage when a predetermined torque limit is exceeded.
A method for producing a high-purity cyclohexenone long-chain alcohol represented by formula I, achieved by the following reaction scheme: wherein R 4 represents R 5 represents amino, the method comprising the steps of subjecting a cyclohexenone long-chain alcohol crude product III and hydrazine derivative R 4 NHNH 2 to a condensation reaction to obtain a compound II, and hydrolyzing the compound II in the presence of an acidic substance to obtain the high-purity compound I. R 4 represents R 5 represents amino, the method comprising the steps of subjecting a cyclohexenone long-chain alcohol crude product III and hydrazine derivative R 4 NHNH 2 to a condensation reaction to obtain a compound II, and hydrolyzing the compound II in the presence of an acidic substance to obtain the high-purity compound I. subjecting a cyclohexenone long-chain alcohol crude product III and hydrazine derivative R 4 NHNH 2 to a condensation reaction to obtain a compound II, and hydrolyzing the compound II in the presence of an acidic substance to obtain the high-purity compound I.
A system for treating a tissue site, comprising: a dressing including a tissue interface adapted to contact the tissue site and a cover adapted to provide a fluid seal between a therapeutic environment including the tissue interface proximate one side of the cover and a local external environment on the other side of the cover; a positive-pressure source fluidly coupled to a solution source comprising an antimicrobial solution and adapted to actuate the solution source for delivering the solution to the tissue interface; and a negative-pressure source fluidly coupled to the dressing and adapted to provide negative pressure to the therapeutic environment after delivery of the antimicrobial solution to the therapeutic environment; characterized in that the solution comprises an aqueous solution of a peroxy α-keto carboxylic acid. a dressing including a tissue interface adapted to contact the tissue site and a cover adapted to provide a fluid seal between a therapeutic environment including the tissue interface proximate one side of the cover and a local external environment on the other side of the cover; a positive-pressure source fluidly coupled to a solution source comprising an antimicrobial solution and adapted to actuate the solution source for delivering the solution to the tissue interface; and a negative-pressure source fluidly coupled to the dressing and adapted to provide negative pressure to the therapeutic environment after delivery of the antimicrobial solution to the therapeutic environment; characterized in that the solution comprises an aqueous solution of a peroxy α-keto carboxylic acid.
A luminescently labeled nucleotide comprising: a nucleoside polyphosphate, wherein the nucleoside polyphosphate comprises one or more luminescent labels attached to the terminal phosphate of the nucleoside polyphosphate via a nucleic acid linker, wherein the nucleic acid linker comprises at least one energy-absorbing modification or one or more unlabeled stem-loops located between the one or more luminescent labels and the nucleoside polyphosphate, and wherein the at least one energy-absorbing modification comprises one or more of the following: a triplet state quencher, a dendron modification, a monosaccharide-TEG, a disaccharide, and an N-acetyl monosaccharide.
Process for applying a noise reducing element to a tyre for vehicle wheels, comprising: a) providing a noise reducing element ; b) providing a first conveyor belt movable along a feeding direction (A) and having, on an upper surface thereof, a continuous film supporting a layer of adhesive material ; c) guiding said noise reducing element according to a predetermined direction, wherein guiding said noise reducing element comprises arranging said noise reducing element on the upper surface of the first conveyor belt ; d) during said guiding, applying said adhesive material onto a first surface of said noise reducing element ; e) interacting by means of a manipulator with a second surface of said noise reducing element different from said first surface on which said adhesive material has been applied; f) positioning said noise reducing element , by said manipulator, in a predetermined position on a radially inner surface of said tyre , bringing said first surface into contact with said radially inner surface . a) providing a noise reducing element ; b) providing a first conveyor belt movable along a feeding direction (A) and having, on an upper surface thereof, a continuous film supporting a layer of adhesive material ; c) guiding said noise reducing element according to a predetermined direction, wherein guiding said noise reducing element comprises arranging said noise reducing element on the upper surface of the first conveyor belt ; d) during said guiding, applying said adhesive material onto a first surface of said noise reducing element ; e) interacting by means of a manipulator with a second surface of said noise reducing element different from said first surface on which said adhesive material has been applied; f) positioning said noise reducing element , by said manipulator, in a predetermined position on a radially inner surface of said tyre , bringing said first surface into contact with said radially inner surface .
An amide compound that is an inhibitor of human receptor interacting protein 1 kinase (RIP1), of formula: wherein: R 1 is substituted or unsubstituted phenyl; R 2 is hydroxyl; R 3 is H; and R 4 is 1,1-dimethylpropyl; or a pharmaceutically acceptable salt, hydrate or stereoisomer of the compound for use in the treatment of a necrosis-associated disease or condition selected from the group consisting of: neurodegenerative disease of the central or peripheral nervous system, endotoxic/septic shock, terminal ileitis, myocarditis, arthritis, atherosclerosis, acute enteritis, ischemic necrosis, pathology resulting from renal failure or cell death, including retinal neuronal, cardiac muscle or immune cell death, such as chemo-or radiation-induced necrosis; liver disease, including drug-induced liver damage or toxicity, acute hepatitis, pancreatic disease, including necrotizing pancreatitis, heart, mesenteric, retinal, hepatic or brain/cerebral ischemic injury, nephritis, ischemic injury during reperfusion or organ storage, head trauma, including traumatic brain injury, stroke, septic shock, coronary heart disease, cardiomyopathy, myocardial infarction, bone avascular necrosis, sickle cell disease, muscle wasting, gastrointestinal disease, tuberculosis, diabetes, pathogenic alteration of blood vessels, muscular dystrophy, graft-versus-host disease, viral, bacterial and fungal infection, Crohn's disease, ulcerative colitis or asthma, comprising administering an effective amount of a compound or a pharmaceutical composition to a patient in need thereof. R 1 is substituted or unsubstituted phenyl; R 2 is hydroxyl; R 3 is H; and R 4 is 1,1-dimethylpropyl; or a pharmaceutically acceptable salt, hydrate or stereoisomer of the compound for use in the treatment of a necrosis-associated disease or condition selected from the group consisting of: neurodegenerative disease of the central or peripheral nervous system, endotoxic/septic shock, terminal ileitis, myocarditis, arthritis, atherosclerosis, acute enteritis, ischemic necrosis, pathology resulting from renal failure or cell death, including retinal neuronal, cardiac muscle or immune cell death, such as chemo-or radiation-induced necrosis; liver disease, including drug-induced liver damage or toxicity, acute hepatitis, pancreatic disease, including necrotizing pancreatitis, heart, mesenteric, retinal, hepatic or brain/cerebral ischemic injury, nephritis, ischemic injury during reperfusion or organ storage, head trauma, including traumatic brain injury, stroke, septic shock, coronary heart disease, cardiomyopathy, myocardial infarction, bone avascular necrosis, sickle cell disease, muscle wasting, gastrointestinal disease, tuberculosis, diabetes, pathogenic alteration of blood vessels, muscular dystrophy, graft-versus-host disease, viral, bacterial and fungal infection, Crohn's disease, ulcerative colitis or asthma, comprising administering an effective amount of a compound or a pharmaceutical composition to a patient in need thereof.
A catalyst system for oxidative dehydrogenation, wherein a reactor is filled with a catalyst for oxidative dehydrogenation in an n-layer structure, wherein n is an integer of 2 or more, wherein the catalyst is diluted and the reactor is filled with the diluted catalyst so that each layer of the n-layer structure satisfies Equations 1 and 2 below: X wt % + Y wt % + Z wt % = 100 wt % , wherein X represents an amount of AB 2 O 4 and is 3 to 30, wherein AB 2 O 4 is a active ingredient of a catalyst, wherein A is one or more selected from the group consisting of copper (Cu), radium (Ra), barium (Ba), strontium (Sr), calcium (Ca), beryllium (Be), zinc (Zn), magnesium (Mg), manganese (Mn), cerium (Ce), zirconium (Zr), lanthanum (La), and cobalt (Co) and B is iron (Fe); Y is an amount of a porous support and is 20 to 97; and Z is an amount of one or more dilution fillers selected from alumina, silica, silicon carbide, zirconia, titania, and cordierite and is 0 to 77, wherein the diluted catalyst is a mixture of the dilution filler and the coating catalyst, the coating catalyst having a porous support coated with the active ingredient AB 2 O 4 ; X n > X n − 1 , wherein, with respect to a direction in which reactants are fed into the reactor, X n represents X for an n-th layer, and X n-1 represents X for an (n-1)th layer, wherein at least one of the n layers has a Z value greater than 0, and wherein the porous support has a packing density of 0.8 to 1.5 g/cm 3 . wherein the catalyst is diluted and the reactor is filled with the diluted catalyst so that each layer of the n-layer structure satisfies Equations 1 and 2 below: X wt % + Y wt % + Z wt % = 100 wt % , wherein X represents an amount of AB 2 O 4 and is 3 to 30, wherein AB 2 O 4 is a active ingredient of a catalyst, wherein A is one or more selected from the group consisting of copper (Cu), radium (Ra), barium (Ba), strontium (Sr), calcium (Ca), beryllium (Be), zinc (Zn), magnesium (Mg), manganese (Mn), cerium (Ce), zirconium (Zr), lanthanum (La), and cobalt (Co) and B is iron (Fe); Y is an amount of a porous support and is 20 to 97; and Z is an amount of one or more dilution fillers selected from alumina, silica, silicon carbide, zirconia, titania, and cordierite and is 0 to 77, wherein the diluted catalyst is a mixture of the dilution filler and the coating catalyst, the coating catalyst having a porous support coated with the active ingredient AB 2 O 4 ; X n > X n − 1 , wherein, with respect to a direction in which reactants are fed into the reactor, X n represents X for an n-th layer, and X n-1 represents X for an (n-1)th layer, wherein at least one of the n layers has a Z value greater than 0, and
A combustor assembly for a gas turbine engine defining an axial direction (A) and a circumferential direction (C) and including structural component, the combustor assembly comprising: a combustor dome ; a liner attached to or formed integrally with the combustor dome and extending between a forward end and an aft end , the combustor dome and liner together defining at least in part a combustion chamber ; a mounting assembly attached to the liner proximate the forward end of the liner for supporting the combustor dome and liner within the gas turbine engine relative to the structural component of the gas turbine engine; wherein the liner comprises a coupling flange at the forward end extending outward from the combustion chamber , wherein the combustor dome also includes a coupling flange extending outward relative to the combustion chamber and positioned adjacent to the coupling flange of the liner , and wherein the mounting assembly attaches the coupling flange of the liner to the coupling flange of the combustor dome ; and wherein the coupling flanges extend outwardly generally along a radial direction R. a combustor dome ; a liner attached to or formed integrally with the combustor dome and extending between a forward end and an aft end , the combustor dome and liner together defining at least in part a combustion chamber ; a mounting assembly attached to the liner proximate the forward end of the liner for supporting the combustor dome and liner within the gas turbine engine relative to the structural component of the gas turbine engine; wherein the liner comprises a coupling flange at the forward end extending outward from the combustion chamber , wherein the combustor dome also includes a coupling flange extending outward relative to the combustion chamber and positioned adjacent to the coupling flange of the liner , and wherein the mounting assembly attaches the coupling flange of the liner to the coupling flange of the combustor dome ; and wherein the coupling flanges extend outwardly generally along a radial direction R.
An imaging device (20; 20A; 40) comprising: an imaging unit to obtain a captured image of a test pattern (TP) and a reference mark (F) to locate the test pattern (TP), the test pattern (TP) including a pair of first marks (M1a, M1b) and a second mark (M2); and at least one processor including: a position detector configured to detect the reference mark (F) in the captured image and locate the pair of first marks (M1a, M1b) and the second mark (M2) in the captured image with reference to the reference mark (F); and characterized in that the at least one processor includes a ratio calculator configured to calculate one of: a first ratio between a distance between the pair of first marks (M1a, M1b) in the captured image and a deviation of the second mark (M2) in the captured image, and a second ratio between the distance between the pair of first marks (M1a, M1b) in the captured image and a distance from one of the pair of first marks (M1a, M1b) to the second mark (M2) in the captured image. an imaging unit to obtain a captured image of a test pattern (TP) and a reference mark (F) to locate the test pattern (TP), the test pattern (TP) including a pair of first marks (M1a, M1b) and a second mark (M2); and at least one processor including: a position detector configured to detect the reference mark (F) in the captured image and locate the pair of first marks (M1a, M1b) and the second mark (M2) in the captured image with reference to the reference mark (F); and characterized in that the at least one processor includes a ratio calculator configured to calculate one of: a first ratio between a distance between the pair of first marks (M1a, M1b) in the captured image and a deviation of the second mark (M2) in the captured image, and a second ratio between the distance between the pair of first marks (M1a, M1b) in the captured image and a distance from one of the pair of first marks (M1a, M1b) to the second mark (M2) in the captured image. a position detector configured to detect the reference mark (F) in the captured image and locate the pair of first marks (M1a, M1b) and the second mark (M2) in the captured image with reference to the reference mark (F); and characterized in that the at least one processor includes a ratio calculator configured to calculate one of: a first ratio between a distance between the pair of first marks (M1a, M1b) in the captured image and a deviation of the second mark (M2) in the captured image, and a second ratio between the distance between the pair of first marks (M1a, M1b) in the captured image and a distance from one of the pair of first marks (M1a, M1b) to the second mark (M2) in the captured image. a first ratio between a distance between the pair of first marks (M1a, M1b) in the captured image and a deviation of the second mark (M2) in the captured image, and a second ratio between the distance between the pair of first marks (M1a, M1b) in the captured image and a distance from one of the pair of first marks (M1a, M1b) to the second mark (M2) in the captured image.
A wind turbine blade for a wind turbine , the wind turbine blade comprising an electrical conductor extending in a longitudinal direction (L) of the wind turbine blade , and a carbon fiber material being electrically conductive and having a first portion which is arranged beside the electrical conductor , a second portion which is connected to the first portion and is attached and electrically connected to the electrical conductor , and a third portion which is connected to the second portion and at least partially overlaps with the first portion , wherein the third portion comprises one part which overlaps with the first portion and another part which does not overlap with the first portion , characterized in that the one part is triangular shaped.
An apparatus (200; 300; 400) for forming an elongated component of glass (260; 360; 460) with low bow, the apparatus (200; 300; 400) comprising: a heating element (240; 340; 440) to heat a bulk glass component (250; 350; 450) where a strand (260; 360; 460) may be drawn from the bulk glass component (250; 350; 450) in a downward z direction; and a gripper device (210; 310; 410a; 410b; 410c), wherein the gripper device (210; 310; 410a; 410b; 410c) comprises: a clamping element (214; 314) to support the strand (260; 360; 460) and move linearly with the strand (260; 360; 460) while it is drawn from the bulk glass component (250; 350; 450), characterized in that the gripper device (210; 310; 410a; 410b; 410c) further comprises: a low-friction mounting element (216; 316) attached to the clamping element (214; 314) which allows translational movement of the clamping element (214; 314) in an x-y plane, wherein a force applied to the clamping element (214; 314) by the strand (260; 360; 460) will result in the clamping element (214; 314) being deflected along the mounting element (216; 316). a heating element (240; 340; 440) to heat a bulk glass component (250; 350; 450) where a strand (260; 360; 460) may be drawn from the bulk glass component (250; 350; 450) in a downward z direction; and a gripper device (210; 310; 410a; 410b; 410c), wherein the gripper device (210; 310; 410a; 410b; 410c) comprises: a clamping element (214; 314) to support the strand (260; 360; 460) and move linearly with the strand (260; 360; 460) while it is drawn from the bulk glass component (250; 350; 450), a low-friction mounting element (216; 316) attached to the clamping element (214; 314) which allows translational movement of the clamping element (214; 314) in an x-y plane, wherein a force applied to the clamping element (214; 314) by the strand (260; 360; 460) will result in the clamping element (214; 314) being deflected along the mounting element (216; 316).
An apparatus for examining a human patient with a support for the patient , at least one display device - especially designed as a screen - which can be viewed by the patient situated on the support , at least two measuring devices for recording measurement data from the patient , which display measurement data relating to the condition of the patient, and an electronic evaluation device , which is connected to the display device and the measuring device , and which is designed to determine output signals based on measurement data obtained from at least two different measuring devices and the correlation thereof, wherein at least one display device and at least one sensor of a measuring device are mounted movably relative to the support for the patient , characterized in that the at least one display device and the at least one sensor of a measuring device is mounted on a support device so as to be movable via a motor, and that the at least one measuring device comprises a medical thermoscanner.